Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles Cell Death and Disease Year : 2020

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma

Hicham Janati
  • Function : Author
  • PersonId : 1113746
Claire Pecqueur
Catherine Gratas
  • Function : Author
  • PersonId : 1033035
François Vallette
  • Function : Author
  • PersonId : 899658

Abstract

Drug resistance limits the therapeutic efficacy in cancers and leads to tumor recurrence through ill-defined mechanisms. Glioblastoma (GBM) are the deadliest brain tumors in adults. GBM, at diagnosis or after treatment, are resistant to temozolomide (TMZ), the standard chemotherapy. To better understand the acquisition of this resistance, we performed a longitudinal study, using a combination of mathematical models, RNA sequencing, single cell analyses, functional and drug assays in a human glioma cell line (U251). After an initial response characterized by cell death induction, cells entered a transient state defined by slow growth, a distinct morphology and a shift of metabolism. Specific genes expression associated to this population revealed chromatin remodeling. Indeed, the histone deacetylase inhibitor trichostatin (TSA), specifically eliminated this population and thus prevented the appearance of fast growing TMZ-resistant cells. In conclusion, we have identified in glioblastoma a population with tolerant-like features, which could constitute a therapeutic target.
Fichier principal
Vignette du fichier
s41419-019-2200-2.pdf (2.99 Mo) Télécharger le fichier
Origin Files produced by the author(s)
Loading...

Dates and versions

hal-02429194 , version 1 (06-01-2020)

Identifiers

Cite

Marion Rabé, Solenne Dumont, Arturo Álvarez-Arenas, Hicham Janati, Juan Belmonte-Beitia, et al.. Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma. Cell Death and Disease, 2020, 11 (1), ⟨10.1038/s41419-019-2200-2⟩. ⟨hal-02429194⟩
226 View
83 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More